No abstract available
MeSH terms
-
Anticoagulants / therapeutic use
-
Antineoplastic Agents / adverse effects
-
Antiphospholipid Syndrome / drug therapy
-
Antiphospholipid Syndrome / immunology*
-
Antiphospholipid Syndrome / pathology
-
Biopsy
-
Calcium Channel Blockers / therapeutic use
-
Dendritic Cells / immunology
-
Dendritic Cells / transplantation
-
Drug Therapy, Combination
-
Hand
-
Humans
-
Immunotherapy / adverse effects*
-
Interferon alpha-2
-
Interferon-alpha / adverse effects
-
Lymphatic Metastasis
-
Male
-
Melanoma / immunology
-
Melanoma / secondary
-
Melanoma / therapy*
-
Middle Aged
-
Necrosis
-
Polyethylene Glycols / adverse effects
-
Recombinant Proteins
-
Skin / immunology*
-
Skin / pathology
-
Toes
-
Treatment Outcome
Substances
-
Anticoagulants
-
Antineoplastic Agents
-
Calcium Channel Blockers
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Polyethylene Glycols
-
peginterferon alfa-2b